US EditionEpidemiology and excess mortality of antimicrobial resistance in bacteraemias among cancer patients: a cohort study using routinely collected health data from regional hospital trusts in Oxford and Oslo, 2008-2018 - AMR Insights
Summary by AMR Insights
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Epidemiology and excess mortality of antimicrobial resistance in bacteraemias among cancer patients: a cohort study using routinely collected health data from regional hospital trusts in Oxford and Oslo, 2008-2018 - AMR Insights
The study examined the epidemiology and impact of antimicrobial resistance (AMR) on cancer patients with bacteraemia at Oxford University Hospitals (OxUH) and Oslo University Hospital (OsUH) from 2008-2018. The study found that the highest resistance proportions were found for vancomycin-resistance in enterococci, carbapenem-resistance in Pseudomonas aeruginosa, and third-generation cephalosporin-resistance in Escherichia coli and Klebsiella pne…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
